Hikma Pharmaceuticals Aktie
23,80
EUR
+0,20
EUR
+0,85
%
19,89
GBP
+0,01
GBP
+0,05
%
Hikma Pharmaceuticals Aktie Analyse
14.12.12 | Hikma Pharmaceuticals overweight | Morgan Stanley | |
15.10.12 | Hikma Pharmaceuticals overweight | J.P. Morgan Cazenove | |
10.10.11 | Hikma Pharmaceuticals buy | Citigroup Corp. | |
21.07.09 | Hikma Pharmaceuticals | Global Biotech Investing |